Micro-Tech Nanjing Co Ltd
SSE:688029
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
56.6
98.82
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Micro-Tech Nanjing Co Ltd
Income from Continuing Operations
Micro-Tech Nanjing Co Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
M
|
Micro-Tech Nanjing Co Ltd
SSE:688029
|
Income from Continuing Operations
ÂĄ494.7m
|
CAGR 3-Years
23%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Income from Continuing Operations
ÂĄ2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
||
Autobio Diagnostics Co Ltd
SSE:603658
|
Income from Continuing Operations
ÂĄ1.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
||
Winner Medical Co Ltd
SZSE:300888
|
Income from Continuing Operations
ÂĄ628.5m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
||
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Income from Continuing Operations
ÂĄ1.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
||
Intco Medical Technology Co Ltd
SZSE:300677
|
Income from Continuing Operations
ÂĄ750.6m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
Micro-Tech Nanjing Co Ltd
Glance View
Micro-Tech (Nanjing) Co., Ltd. engages in the manufacture of medical equipment. The company is headquartered in Nanjing, Jiangsu and currently employs 2,315 full-time employees. The company went IPO on 2019-07-22. The firm's main products include three series of endoscopic diagnosis and treatment instruments used with endoscopes, microwave ablation equipment and consumables, and disposable endoscopes. Endoscopic diagnosis and treatment equipment mainly includes biopsy, hemostasis and closure, Endoscopic Mucosal Resection (EMR)/Endoscopic Submucosal Dissection (ESD), dilation, and Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Ultrasonography (EUS) and Endobronchial Ultrasound (EBUS) products. Microwave ablation mainly includes microwave ablation instrument and microwave ablation needle series products. Disposable endoscope mainly includes disposable biliopancreatic imaging system (choledochoscope) and related consumables and other products.
See Also
What is Micro-Tech Nanjing Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
494.7m
CNY
Based on the financial report for Dec 31, 2023, Micro-Tech Nanjing Co Ltd's Income from Continuing Operations amounts to 494.7m CNY.
What is Micro-Tech Nanjing Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
19%
Over the last year, the Income from Continuing Operations growth was 49%. The average annual Income from Continuing Operations growth rates for Micro-Tech Nanjing Co Ltd have been 23% over the past three years , 19% over the past five years .